SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001623613-20-000014
Filing Date
2020-05-11
Accepted
2020-05-11 08:47:44
Documents
15
Period of Report
2020-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kerngsrls20200331doc.htm   iXBRL 8-K 46685
2 EXHIBIT 99.1 exhibit991-1q20earning.htm EX-99.1 517784
  Complete submission text file 0001623613-20-000014.txt   763737

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT myl-20200331.xsd EX-101.SCH 4285
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT myl-20200331_cal.xml EX-101.CAL 613
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT myl-20200331_def.xml EX-101.DEF 1463
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT myl-20200331_lab.xml EX-101.LAB 29298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT myl-20200331_pre.xml EX-101.PRE 15111
11 EXTRACTED XBRL INSTANCE DOCUMENT a8-kerngsrls20200331doc_htm.xml XML 4670
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

IRS No.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-199861 | Film No.: 20862818
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences